Q/LAIV (MEDI3250)

BIOLOGICAL2 trials

Sponsors

MedImmune LLC

Conditions

Healthy or Stable Chronic IllnessHealthy or Stable Underlying Chronic Medical Condition

Phase 2

A Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Adults 18 to 49 Years of Age

CompletedNCT00860067

MedImmune LLCHealthy or Stable Underlying Chronic Medical Condition

Start: 2009-03-31End: 2009-10-31Updated: 2011-12-05

Phase 3

A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children

CompletedNCT01091246

MedImmune LLCHealthy or Stable Chronic Illness

Start: 2010-03-31End: 2010-12-31Updated: 2011-09-26